Saccharopolyspora erythraea-catalyzed bioconversion of 6-deoxyerythronolide B (cas 15797-36-1) analogs for production of novel erythromycins

Add time:09/27/2019    Source:sciencedirect.com

A method was developed for the large-scale bioconversion of novel 6-deoxyerythronolide B (cas 15797-36-1) (6-dEB) analogs into erythromycin analogs. Erythromycin biosynthesis in Saccharopolyspora erythraea proceeds via the formation of a polyketide aglycone, 6-dEB, which is subsequently glycosylated, hydroxylated and methylated to yield the antibiotic erythromycin A. A modular polyketide synthase (PKS) directs 6-dEB synthesis using a dedicated set of active sites for the condensation of each of seven propionate units. Strategies based on genetic manipulation and precursor feeding are available for the efficient generation of novel 6-dEB analogs using a plasmid-based system in Streptomyces coelicolor. 6-dEB and 13-substituted 6-dEB analogs produced in this manner were fed to S. erythraea mutants which could not produce 6-dEB, yet retained their 6-dEB modification systems, and resulted in the generation of erythromycin A and 13-substituted erythromycin A analogs. Erythromycin B, C and D analogs were observed as intermediates of the process. Dissolved oxygen, temperature, the specific aglycone feed concentration, and pH were found to be important for obtaining a high yield of erythromycin A analogs. Cultivation conditions were identified which resulted in the efficient bioconversion of 6-dEB analogs into erythromycin A analogs, which this process demonstrated at the 100 l scale.

We also recommend Trading Suppliers and Manufacturers of 6-deoxyerythronolide B (cas 15797-36-1). Pls Click Website Link as below: cas 15797-36-1 suppliers

Prev:Synthesis of 6-deoxyerythronolide B (cas 15797-36-1). Implementation of a general strategy for the synthesis of macrolide antibiotics
Next:Catalyst-free Friedel-Crafts reaction of 1-(N-acylamino)alkyltriarylphosphonium salts with electron-rich arenes)